Hydrochloric Acid → 1-(4-chloro-phenyl)-3-(piperidin-4-yloxy)-1H-indazole hydrochloride

HRID 30403Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 30403
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([O:14][C:15]2[C:23]3[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=3)[N:17]([C:24]3[CH:29]=[CH:28][C:27]([Cl:30])=[CH:26][CH:25]=3)[N:16]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.Cl.O1CCOCC1>CCOC(C)=O>[ClH:30].[Cl:30][C:27]1[CH:28]=[CH:29][C:24]([N:17]2[C:18]3[C:23](=[CH:22][CH:21]=[CH:20][CH:19]=3)[C:15]([O:14][CH:11]3[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]3)=[N:16]2)=[CH:25][CH:26]=1

Komponenten

5

Edukt 3

HCID 313Hydrochloric AcidHCID 312751,4-DioxaneHCID 685301764-[1-(4-chloro-phenyl)-1H-indazol-3-yloxy]-piperidine-1-carboxylic acid tert-butyl ester

Produkt 1

HCID 574205501-(4-chloro-phenyl)-3-(piperidin-4-yloxy)-1H-indazole hydrochlorideAusbeute 171,9 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

Intermediate 42 (212 mg, 0.495 mmol) was dissolved in EtOAc (2 ml), treated with 4M HCl in dioxane (1.61 ml, 6.44 mmol) and stirred overnight at room temperature. The mixture was concentrated in vacuo, treated with EtOAc and concentrated again. This process was repeated 5 times. The resulting white solid was triturated with Et2O, filtered, rinsed with Et2O and dried in a vacuum oven at 50° C. to afford 155 mg (86%) of the title product—1-(4-chloro-phenyl)-3-(piperidin-4-yloxy)-1H-indazole hydrochloride as a white solid.

Aufarbeitung

  1. concentrationThe mixture was concentrated in vacuo
  2. additiontreated with EtOAc
  3. concentrationconcentrated again
  4. customThe resulting white solid was triturated with Et2O
  5. filtrationfiltered
  6. washrinsed with Et2O
  7. customdried in a vacuum oven at 50° C.

Quellen und Nachweise

ORD-Eintrag
ord-90ee85a79c5f4fa7aa801a35fb58813c
Quelldatensatz
uspto-grants-2008_09
Patentnummer
US07423054B2

Notizen zur Reaktion

Wird geladen…